Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA.
Christian SchmidkonzManuela KrumbholzArmin AtzingerMichael CordesTheresa Ida GoetzOlaf PrantePhilipp RittChristiane SchaeferAbbas AgaimyWolfgang HartmannClaudia RössigBirgit FröhlichTobias BäuerleUta DirksenTorsten KuwertMarkus MetzlerPublished in: European journal of nuclear medicine and molecular imaging (2019)
The combination of 18F-FDG-PET/CT and ctDNA quantification is a very promising noninvasive tool for assessing treatment responses and detecting tumor relapses in children and young adolescents suffering from EwS who are undergoing multimodal chemotherapy.